• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT311413
Device Problems Material Invagination (1336); Off-Label Use (1494); Patient-Device Incompatibility (2682)
Patient Problems Death (1802); Blood Loss (2597)
Event Date 01/08/2018
Event Type  Death  
Manufacturer Narrative
(b)(4).Patient medications include aspirin, lipitor, cardura, hydrazine, hydrochlorothiazide, and lopressor.A review of the manufacturing records for the device verified that the lot met all pre-release specifications.Per the gore® excluder® aaa endoprosthesis instructions for use (ifu), the safety and effectiveness of the gore® excluder® aaa endoprosthesis have not been evaluated in patients with pending rupture or ruptured aneurysms, or patients with greater than 60 degrees angulation of the proximal aortic neck.Per ifu, adverse events that may occur and/or require intervention include, but are not limited to improper endoprosthesis component placement and death.
 
Event Description
On (b)(6) 2018, the patient presented emergently to the facility with a ruptured abdominal aortic aneurysm.The physician implanted two gore® excluder® aaa endoprostheses (rlt311413/17270729 and plc161000/17248503) to treat the rupture.According to the report, the patient¿s anatomy featured a 90-degree turn in the infrarenal aortic neck.The decision was made to land the proximal endoprosthesis below the angulated turn.Both devices were implanted without any reported issues, and the patient tolerated the procedure.On the following day, the patient expired.A computed tomography scan on this day reportedly showed that the proximal trunk had unintentionally been placed above the angulated turn in the infrarenal neck.The physician believes this positioning caused increased pressure against the proximal end of the endograft once blood flow was restored during the procedure.The increased pressure reportedly caused the proximal end to infold, which led to blood flowing around the graft and out of the ruptured aneurysm sac.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
damon jackson
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7215701
MDR Text Key98114384
Report Number3007284313-2018-00033
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/24/2020
Device Catalogue NumberRLT311413
Device Lot Number17270729
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/24/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/25/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age76 YR
Patient Weight93
-
-